Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

More research is needed to understand and manage rheumatoid arthritis better.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Higher BMI may increase the risk of psoriasis and some other skin diseases.

New technologies help better understand and treat inflammatory skin diseases.

Histone modification is key in treating chronic inflammatory skin diseases.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

New therapies for rare skin diseases show promise but need more research.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Fzd2 is important for skin and hair development through various signaling ways.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.